Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?

P G Sørensen, Mogens Holst Nissen, S Groth, M Rørth

19 Citationer (Scopus)

Abstract

Udgivelsesdato: 1985-null

Originalsprog	Engelsk
Tidsskrift	Cancer Chemotherapy and Pharmacology
Vol/bind	14
Udgave nummer	3
Sider (fra-til)	247-9
Antal sider	2
ISSN	0344-5704
Status	Udgivet - 1985

Citationsformater

@article{2dbffca0ba3611ddae57000ea68e967b,

title = "Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?",

abstract = "To evaluate the value of beta-2-microglobulin as an indicator of acute and long-term cis-platinum-induced nephrotoxicity, 51Cr-EDTA clearance and serum concentration and urinary excretion of beta-2-microglobulin were measured in 18 patients treated with a regimen including cis-platinum. Before treatment all values were within the normal range. During treatment 51Cr-EDTA clearance decreased from 108 to 90 ml/min/1.73 m2 (P less than 0.02). The decrease was irreversible, while a transient 2 to 5-fold increase in beta-2-microglobulin excretion in the urine was seen during treatment. Serum beta-2-microglobulin remained unchanged. The decrease in 51Cr-EDTA clearance was not correlated to either the peak increase in the beta-2-microglobulin excretion or to the time of occurrence of the peak (R = 0.3). Thus, it is not possible to predict the long-term nephrotoxicity of cis-platinum by measuring the beta-2-microglobulin excretion during treatment.",

author = "S{\o}rensen, {P G} and Nissen, {Mogens Holst} and S Groth and M R{\o}rth",

note = "Keywords: Adolescent; Adult; Cisplatin; Edetic Acid; Glomerular Filtration Rate; Humans; Kidney; beta 2-Microglobulin",

year = "1985",

language = "English",

volume = "14",

pages = "247--9",

journal = "Cancer Chemotherapy and Pharmacology, Supplement",

issn = "0943-9404",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?

AU - Sørensen, P G

AU - Nissen, Mogens Holst

AU - Groth, S

AU - Rørth, M

N1 - Keywords: Adolescent; Adult; Cisplatin; Edetic Acid; Glomerular Filtration Rate; Humans; Kidney; beta 2-Microglobulin

PY - 1985

Y1 - 1985

N2 - To evaluate the value of beta-2-microglobulin as an indicator of acute and long-term cis-platinum-induced nephrotoxicity, 51Cr-EDTA clearance and serum concentration and urinary excretion of beta-2-microglobulin were measured in 18 patients treated with a regimen including cis-platinum. Before treatment all values were within the normal range. During treatment 51Cr-EDTA clearance decreased from 108 to 90 ml/min/1.73 m2 (P less than 0.02). The decrease was irreversible, while a transient 2 to 5-fold increase in beta-2-microglobulin excretion in the urine was seen during treatment. Serum beta-2-microglobulin remained unchanged. The decrease in 51Cr-EDTA clearance was not correlated to either the peak increase in the beta-2-microglobulin excretion or to the time of occurrence of the peak (R = 0.3). Thus, it is not possible to predict the long-term nephrotoxicity of cis-platinum by measuring the beta-2-microglobulin excretion during treatment.

AB - To evaluate the value of beta-2-microglobulin as an indicator of acute and long-term cis-platinum-induced nephrotoxicity, 51Cr-EDTA clearance and serum concentration and urinary excretion of beta-2-microglobulin were measured in 18 patients treated with a regimen including cis-platinum. Before treatment all values were within the normal range. During treatment 51Cr-EDTA clearance decreased from 108 to 90 ml/min/1.73 m2 (P less than 0.02). The decrease was irreversible, while a transient 2 to 5-fold increase in beta-2-microglobulin excretion in the urine was seen during treatment. Serum beta-2-microglobulin remained unchanged. The decrease in 51Cr-EDTA clearance was not correlated to either the peak increase in the beta-2-microglobulin excretion or to the time of occurrence of the peak (R = 0.3). Thus, it is not possible to predict the long-term nephrotoxicity of cis-platinum by measuring the beta-2-microglobulin excretion during treatment.

M3 - Journal article

C2 - 3922640

SN - 0943-9404

VL - 14

SP - 247

EP - 249

JO - Cancer Chemotherapy and Pharmacology, Supplement

JF - Cancer Chemotherapy and Pharmacology, Supplement

IS - 3

ER -